Eisler Capital (UK)’s Intelligent Medicine Acquisition Corp. Class A Common Stock IQMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-80,145
Closed -$803K 397
2022
Q2
$803K Buy
+80,145
New +$801K 0.03% 265

Other funds holding IQMD

Eisler Capital (UK)'s IQMD Position: Q3 2022 in Review

Eisler Capital (UK) sold out of Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) in Q3 2022, closing a stake of 80,145 shares — an estimated $803K sold.

Eisler Capital (UK) first reported a position in IQMD in Q2 2022 and held it in 1 quarter. The position peaked at $803K in Q2 2022. 58 funds tracked by Wall St. Rank hold IQMD as of Q3 2022.

  • Eisler Capital (UK) reported no remaining Intelligent Medicine Acquisition Corp. Class A Common Stock position as of Q3 2022 after selling out during the quarter.
  • Eisler Capital (UK) sold 80,145 Intelligent Medicine Acquisition Corp. Class A Common Stock shares in Q3 2022, an estimated $803K.
  • Eisler Capital (UK) first reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock in Q2 2022 and held it in 1 quarter.
  • Eisler Capital (UK)'s Intelligent Medicine Acquisition Corp. Class A Common Stock position peaked at $803K in Q2 2022.
  • 58 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Class A Common Stock as of Q3 2022.

Based on Eisler Capital (UK)'s 13F filing for Q3 2022, filed 14 Nov 2022.